SCHEMBL975081

SCHEMBL975081

CCCCCCCCCCCCCC[N+]1(C)CCOCC1.COS(=O)(=O)[O-]

nearest known ligand 0.53

Known targets — ChEMBL curated mechanism

ACHECHRM1CHRM3

The experimentally established mechanism targets of None. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ACHE known ✓ P22303 1/20 0.32
CDC25A P30304 1/20 0.53
GNAI3 P08754 1/20 0.40
GNAO1 P09471 1/20 0.40
GNAI1 P63096 1/20 0.40
HPGD P15428 2/20 0.39
ALOX15 P16050 1/20 0.39
RECQL P46063 2/20 0.38
TSHR P16473 2/20 0.38
GLA P06280 1/20 0.38
MAPK1 P28482 1/20 0.38
EPHX2 P34913 1/20 0.38
BLM P54132 1/20 0.38
PABPC1 P11940 2/20 0.35
APOBEC3A P31941 3/20 0.34
APOBEC3G Q9HC16 3/20 0.34
LMNA P02545 1/20 0.34
KMT2A Q03164 1/20 0.34
CTDSP1 Q9GZU7 1/20 0.34
L3MBTL1 Q9Y468 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL11345454 1.00 CDC25A (0.53) CDC25AGNAI3GNAO1GNAI1HPGD
SCHEMBL17102598 0.94 CDC25A (0.49) CDC25AGNAI3GNAO1GNAI1HPGD
SCHEMBL29150962 0.92 CDC25A (0.47) CDC25AGNAI3GNAO1GNAI1HPGD
SCHEMBL9719402 0.84 LMNA (0.49) CDC25AGNAI3GNAO1GNAI1HPGD
Sulfuric Acid SCHEMBL17102678 0.84 CDC25A (0.50) CDC25AGNAI3GNAO1GNAI1HPGD
SCHEMBL13042277 0.83 CDC25A (0.55) CDC25AGNAI3GNAO1GNAI1HPGD
SCHEMBL4065812 0.83 CDC25A (0.55) CDC25AGNAI3GNAO1GNAI1HPGD
SCHEMBL4752338 0.83 CDC25A (0.55) CDC25AGNAI3GNAO1GNAI1HPGD
SCHEMBL17419072 0.83 CDC25A (0.55) CDC25AGNAI3GNAO1GNAI1HPGD
SCHEMBL4428238 0.83 CDC25A (0.55) CDC25AGNAI3GNAO1GNAI1HPGD

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 83 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3291673-B1 ANTIMICROBIAL COMPOSITIONS AND METHODS FOR REDUCING MICROBIAL CONTAMINATION POLYVATION B V (NL) 2025-07-23 EP claimed
CN-117479965-A Quick-acting aerosol for air disinfection and sterilization 雷克特本克斯尔有限责任公司 2024-01-30 CN claimed
CN-107750124-B Antimicrobial compositions and methods for reducing microbial contamination 波利维逊有限公司 2022-10-28 CN claimed
US-20220313598-A1 Antimicrobial Compositions and Methods For Reducing Microbial Contamination POLYVATION B.V. (NL) 2022-10-06 US claimed
US-11291625-B2 Antimicrobial compositions and methods for reducing microbial contamination POLYVATION B.V. (NL) 2022-04-05 US claimed
US-20180147137-A1 ANTIMICROBIAL COMPOSITIONS AND METHODS FOR REDUCING MICROBIAL CONTAMINATION POLYVATION B.V. (NL) 2018-05-31 US claimed
EP-3291673-A1 ANTIMICROBIAL COMPOSITIONS AND METHODS FOR REDUCING MICROBIAL CONTAMINATION PolyVation B.V. (NL) 2018-03-14 EP claimed
WO-2016178578-A1 ANTIMICROBIAL COMPOSITIONS AND METHODS FOR REDUCING MICROBIAL CONTAMINATION POLYVATION B.V. (NL) 2016-11-10 WO claimed
EP-1455576-B1 ANTIMICROBIAL PRE-MOISTENED WIPERS KIMBERLY CLARK CO (US) 2009-04-01 EP claimed
US-7179849-B2 Antimicrobial compositions containing colloids of oligodynamic metals C. R. BARD, INC. (US) 2007-02-20 US claimed
US-20250268250-A1 TOPICAL ANTISEPTIC SYSTEM Infection Containment Company, LLC 2025-08-28 US disclosed
EP-3291673-B1 ANTIMICROBIAL COMPOSITIONS AND METHODS FOR REDUCING MICROBIAL CONTAMINATION POLYVATION B V (NL) 2025-07-23 EP disclosed
US-12324430-B2 Topical antiseptic system Infection Containment Company, LLC (US) 2025-06-10 US disclosed
CN-119677548-A Quick-acting aerosol for air disinfection and sterilization 雷克特本克斯尔有限责任公司 2025-03-21 CN disclosed
US-20240381869-A1 Color-Changing Sanitizing Compositions and Methods of Use KIMBERLY-CLARK WORLDWIDE, INC. 2024-11-21 US disclosed
US-5705532-A Triple antimicrobial composition THE TRUSTEES OF COLUMBIA UNIVERSITY OF THE CITY OF NEW YORK 1998-01-06 US disclosed
US-RE32300-E Basic amino or ammonium antimicrobial agent-polyethylene glycol ester surfactant-betaine and/or amine oxide surfactant compositions and method of use thereof STERLING DRUG INC. (US) 1986-12-02 US disclosed
US-4420484-A ANTISEPTIC CLEANING COMPOUNDS; SKINS; FROTHS STERLING DRUG INC. (US) 1983-12-13 US disclosed
EP-0024031-B1 Skin cleansing composition STERLING DRUG INC. (US) 1983-11-16 EP disclosed
EP-0024031-A1 Skin cleansing composition STERLING DRUG INC. (US) 1981-02-18 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (6 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-11291625-B2 Antimicrobial compositions and methods for reducing microbial contamination CUTA, VNN1, NACA ACHE 3545/4885CDC25A 2668/4885GNAI3 3823/4885
US-20180147137-A1 ANTIMICROBIAL COMPOSITIONS AND METHODS FOR REDUCING MICROBIAL CONTAMINATION CUTA, VNN1, NACA ACHE 3545/4885CDC25A 2668/4885GNAI3 3823/4885
US-20250268250-A1 TOPICAL ANTISEPTIC SYSTEM CUTA, TREH, NACA ACHE 236/4885CDC25A 4118/4885GNAI3 4239/4885
US-20220313598-A1 Antimicrobial Compositions and Methods For Reducing Microbial Contamination CUTA, VNN1, NACA ACHE 3545/4885CDC25A 2668/4885GNAI3 3823/4885
US-20240381869-A1 Color-Changing Sanitizing Compositions and Methods of Use TREH, SAMHD1, POLR1C ACHE 3900/4885CDC25A 544/4885GNAI3 2765/4885
US-12324430-B2 Topical antiseptic system CUTA, TREH, NACA ACHE 236/4885CDC25A 4118/4885GNAI3 4239/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.